interleukin 1beta (193-195) has been researched along with flumazenil in 1 studies
| Studies (interleukin 1beta (193-195)) | Trials (interleukin 1beta (193-195)) | Recent Studies (post-2010) (interleukin 1beta (193-195)) | Studies (flumazenil) | Trials (flumazenil) | Recent Studies (post-2010) (flumazenil) |
|---|---|---|---|---|---|
| 18 | 0 | 2 | 4,673 | 426 | 981 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, JM; Rady, JJ | 1 |
1 other study(ies) available for interleukin 1beta (193-195) and flumazenil
| Article | Year |
|---|---|
Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice.
Topics: Analgesia; Analgesics, Opioid; Animals; Brain; Dinoprostone; Dose-Response Relationship, Drug; Drug Antagonism; Drug Therapy, Combination; Dynorphins; Flumazenil; Injections, Intraventricular; Injections, Spinal; Interleukin-1; Interleukin-1beta; Male; Mice; Morphine; Nociceptin; Opioid Peptides; Pain Measurement; Peptide Fragments; Spinal Cord | 2002 |